首页> 外文期刊>Biologicals: Journal of the International Association of Biological Standardization >Treatment of Chlamydia-associated ocular disease via a recombinant protein based vaccine in the koala (Phascolarctos cinereus)
【24h】

Treatment of Chlamydia-associated ocular disease via a recombinant protein based vaccine in the koala (Phascolarctos cinereus)

机译:通过一种基于重组蛋白的考拉疫苗在考拉中治疗衣原体相关性眼病(Phascolarctos cinereus)

获取原文
获取原文并翻译 | 示例
       

摘要

Koalas (Phascolarctos cinereus) are affected by debilitating chlamydial disease that can lead to blindness, infertility, and death. The causative agent is the intracellular bacterium Chlamydia pecorum. While antibiotics can be used to treat koala chlamydial infection, they are often ineffective or cause severe dysbiosis to the animal's unique gut flora. Recent work has progressed on the development of a protective vaccine for Chlamydia in the koala. This study demonstrates that the use of a vaccine can have a positive effect in koalas already with clinical signs of ocular disease, suggesting a possible therapeutic effect and an alternative to antibiotic therapy. (C) 2016 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.
机译:考拉(Phascolarctos cinereus)会受到令人虚弱的衣原体疾病的影响,该疾病可能导致失明,不育和死亡。病原体是细胞内细菌衣原体。虽然抗生素可用于治疗考拉衣原体感染,但它们通常无效或对动物独特的肠道菌群造成严重的营养不良。在开发用于考拉衣原体的保护性疫苗方面,最近的工作取得了进展。这项研究表明,疫苗的使用对已经具有眼部疾病临床症状的考拉具有积极作用,表明可能的治疗效果和抗生素治疗的替代方法。 (C)2016国际生物标准化联盟。由Elsevier Ltd.出版。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号